Abstract: An object of the present invention is to provide a therapeutic agent for fatty liver diseases. The above object can be achieved by a therapeutic agent for a fatty liver disease, comprising a compound represented by the following formula (1): or a pharmaceutically acceptable salt thereof.

Abstract: A method for producing an aggregated boron nitride particle, containing: a nitriding step of nitriding a particle containing boron carbide to obtain a particle containing boron carbonitride; and a decarburizing step of decarburizing the particle containing boron carbonitride to obtain an aggregated boron nitride particle, wherein, in the nitriding step, nitriding is performed so that boron carbide remains inside the particle containing boron carbonitride, and wherein, in the decarburizing step, the boron carbide remaining inside the particle containing boron carbonitride is removed.

Abstract: A position of first cursor changes according to a position of thumb. A position of second cursor changes according to a visual line of a user. If a position of first cursor remains unchanged over a predetermined time period, the position of first cursor is fixed. If a distance between first cursor and second cursor has become longer, image G1 on display other than first cursor or second cursor is enlarged. If a distance between first cursor and second cursor has become shorter, image G1 on display other than first cursor or second cursor is reduced.

Abstract: The present invention aims to provide a novel compound having a TRPA1 antagonist activity, and a medicament containing the compound. Moreover, the present invention aims to provide a TRPA1 antagonist and a medicament useful for the prophylaxis or treatment of diseases involving TRPA1. A medicament containing a compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof, and the like.

Abstract: Information-processing device detects a visual line of a user, and displays cursor at the position viewed by the user. If the user touches a display area of an image using his/her finger while cursor is close to an edge of the display area, the position touched by the finger is recorded. When the user moves the finger, a scrolling speed is determined according to a distance the finger is moved and the image is scrolled in the direction of cursor. In a case where the position viewed by the user and a scrolling direction change, and where a line of a scrolling direction before the change crosses a line of a scrolling direction after the change, the scrolling direction changes while the scrolling speed is maintained.

Abstract: Information-processing device detects a visual line of a user, and displays cursor at the position viewed by the user. If the user touches a display area of an image using his/her finger while cursor is close to an edge of the display area, the position touched by the finger is recorded. When the user moves the finger, a scrolling speed is determined according to a distance the finger is moved and the image is scrolled in the direction of cursor. In a case where the position viewed by the user and a scrolling direction change, and where a line of a scrolling direction before the change crosses a line of a scrolling direction after the change, the scrolling direction changes while the scrolling speed is maintained.

Abstract: A position of first cursor changes according to a position of thumb. A position of second cursor changes according to a visual line of a user. If a position of first cursor remains unchanged over a predetermined time period, the position of first cursor is fixed. If a distance between first cursor and second cursor has become longer, image G1 on display other than first cursor or second cursor is enlarged. If a distance between first cursor and second cursor has become shorter, image G1 on display other than first cursor or second cursor is reduced.

Abstract: The present invention aims to provide a novel compound having a TRPA1 antagonist activity, and a medicament containing the compound. Moreover, the present invention aims to provide a TRPA1 antagonist and a medicament useful for the prophylaxis or treatment of diseases involving TRPA1. A medicament containing a compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof, and the like.

Abstract: The present invention provides a more effective gastrointestinal function promoter. The present invention also provides a method for the prophylaxis or improvement of functional gastrointestinal disorders, a method for appetite regulation and the like. The present invention also provides a method for screening for a substance capable of promoting a gastrointestinal function. The present invention provides a gastrointestinal function promoter containing a T1R agonist as an active ingredient and a method for the prophylaxis or improvement of functional gastrointestinal disorders, a method for appetite regulation and the like by administering a T1R agonist. The present invention also provides a method of screening for a substance capable of promoting a gastrointestinal function which method uses a cell expressing T1R receptor.